Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Other liabilities

Other liabilities at other companies

NuSkin Enterprises logo
NuSkin EnterprisesNUS
——

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$394.19M-30.9%
P/E19.7×+8.5×
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's other liabilities?
USANA Health Sciences (USNA) reported other liabilities of -$11.95M in Q1 2026.
How has USANA Health Sciences's other liabilities changed year-over-year?
USANA Health Sciences's other liabilities decreased by 89.6% year-over-year, from -$6.3M to -$11.95M.
What is the long-term trend for USANA Health Sciences's other liabilities?
Over 2 years (2021 to 2025), USANA Health Sciences's other liabilities has grown at a 11.4% compound annual growth rate (CAGR), from -$11.46M to -$14.22M.
What does other liabilities mean?
Captures the net change in miscellaneous short-term operating obligations not classified as accounts payable or accrued expenses. Monitoring this metric helps identify shifts in working capital requirements and the timing of various operational cash outflows.